Page last updated: 2024-08-23

dehydrocorydalin and Disease Models, Animal

dehydrocorydalin has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, W; Jiang, H; Jin, L; Lei, S; Zeng, S; Zhou, H; Zhou, S; Zhu, S1
Chu, SS; Gu, XP; Li, L; Ma, ZL; Sun, Q; Yin, ZY1

Other Studies

2 other study(ies) available for dehydrocorydalin and Disease Models, Animal

ArticleYear
Dehydrocorydaline induced antidepressant-like effect in a chronic unpredictable mild stress mouse model via inhibiting uptake-2 monoamine transporters.
    European journal of pharmacology, 2019, Dec-01, Volume: 864

    Topics: Alkaloids; Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Biological Transport; Brain; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Stress, Psychological; Synaptosomes

2019
Antinociceptive effects of dehydrocorydaline in mouse models of inflammatory pain involve the opioid receptor and inflammatory cytokines.
    Scientific reports, 2016, 06-07, Volume: 6

    Topics: Acetates; Alkaloids; Analgesics; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Formaldehyde; Gene Expression Regulation; Humans; Injections, Intraperitoneal; Mice; Naloxone; Pain; Receptors, Opioid

2016